OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
JAK inhibitors and autoimmune rheumatic diseases
Maurizio Benucci, Pamela Bernardini, Carmela Coccia, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 4, pp. 103276-103276
Open Access | Times Cited: 64
Maurizio Benucci, Pamela Bernardini, Carmela Coccia, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 4, pp. 103276-103276
Open Access | Times Cited: 64
Showing 51-75 of 64 citing articles:
JAK Inhibitors for Treating Steroid-Dependent IgA Vasculitis
Sun Qingmiao, Juan Bai, Su Wang, et al.
American Journal of Therapeutics (2024)
Closed Access
Sun Qingmiao, Juan Bai, Su Wang, et al.
American Journal of Therapeutics (2024)
Closed Access
A retrospective study of efficacy of tofacitinib combined with bDMARDs in the treatment of rheumatoid arthritis patients with inadequate response to bDMARDs
Jie Chang, Gang Wang
Research Square (Research Square) (2024)
Open Access
Jie Chang, Gang Wang
Research Square (Research Square) (2024)
Open Access
Novel insights into the management of rheumatoid arthritis: one year in review 2024
Emanuele Molteni, Antonella Adinolfi, Valentina Bondi, et al.
Clinical and Experimental Rheumatology (2024)
Open Access
Emanuele Molteni, Antonella Adinolfi, Valentina Bondi, et al.
Clinical and Experimental Rheumatology (2024)
Open Access
Tofacitinib versus thalidomide for mucocutaneous lesions of systemic lupus erythematosus: A real-world CSTAR cohort study XXVII
Zhao Man, Leyao Ma, Xinwang Duan, et al.
Lupus (2024) Vol. 33, Iss. 10, pp. 1109-1115
Closed Access
Zhao Man, Leyao Ma, Xinwang Duan, et al.
Lupus (2024) Vol. 33, Iss. 10, pp. 1109-1115
Closed Access
Pharmacological Strategies in Dermatomyositis: Current Treatments and Future Directions
Jinqiang Guo, Weiwei Wang, Anbin Huang, et al.
Medical Science Monitor (2024) Vol. 30
Open Access
Jinqiang Guo, Weiwei Wang, Anbin Huang, et al.
Medical Science Monitor (2024) Vol. 30
Open Access
A retrospective study of efficacy of tofacitinib combined with bDMARDs in the treatment of rheumatoid arthritis patients with inadequate response to bDMARDs
Jie Chang, G. Wang
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 9
Open Access
Jie Chang, G. Wang
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 9
Open Access
PIM1 signaling in immunoinflammatory diseases: an emerging therapeutic target
Xue Yang, Chunming Liu, Yuxi Lei, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Xue Yang, Chunming Liu, Yuxi Lei, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Mitigating neurodegenerative diseases: the protective influence of baicalin and baicalein through neuroinflammation regulation
Rui Yang, Ranran Wang, Ajing Xu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Rui Yang, Ranran Wang, Ajing Xu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Successful treatment with upadacitinib for Sjögren's syndrome complicated by atopic dermatitis
Haojie Xu, Wenwen Pei, Ruyu Liang, et al.
Rheumatology & autoimmunity (2024)
Closed Access
Haojie Xu, Wenwen Pei, Ruyu Liang, et al.
Rheumatology & autoimmunity (2024)
Closed Access
Janus-kinase inhibitor use in immune-mediated inflammatory diseases beyond licensed indications: A scoping review
Dimitris Challoumas, Catherine Simpson, Matthew Arnold, et al.
Autoimmunity Reviews (2024) Vol. 24, Iss. 3, pp. 103736-103736
Open Access
Dimitris Challoumas, Catherine Simpson, Matthew Arnold, et al.
Autoimmunity Reviews (2024) Vol. 24, Iss. 3, pp. 103736-103736
Open Access
Tofacitinib may improve insulin resistance in patients with rheumatoid arthritis and diabetes, implications for disease management and precision medicine approach
Claudia Di Muzio, Francesco Ursini, Annamaria Iagnocco, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 8, pp. 103373-103373
Closed Access | Times Cited: 1
Claudia Di Muzio, Francesco Ursini, Annamaria Iagnocco, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 8, pp. 103373-103373
Closed Access | Times Cited: 1
Drug Retention Rates of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients with Therapy-Induced Lymphopenia
Jumpei Temmoku, Masayuki Miyata, Eiji Suzuki, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4827-4827
Open Access | Times Cited: 1
Jumpei Temmoku, Masayuki Miyata, Eiji Suzuki, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4827-4827
Open Access | Times Cited: 1
Microbiome dynamics in rheumatic diseases
Yiqing Wang, Zijun Wang, Qianjin Lu
Current Opinion in Rheumatology (2023) Vol. 36, Iss. 2, pp. 134-141
Closed Access
Yiqing Wang, Zijun Wang, Qianjin Lu
Current Opinion in Rheumatology (2023) Vol. 36, Iss. 2, pp. 134-141
Closed Access
UPADACITINIB IN ACTION: EFFICACY AND SAFETY IN THE TREATMENT OF RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND AXIAL SPONDYLOARTHRITIS
Fatma Başıbüyük, İ̇̇smail Sarı
Rheumatology Quarterly (2023)
Open Access
Fatma Başıbüyük, İ̇̇smail Sarı
Rheumatology Quarterly (2023)
Open Access
